ZP1

ZP1 is a zona pellucida glycoprotein that serves as the structural crosslinker of the extracellular zona matrix surrounding mammalian oocytes, essential for female fertility. ZP1 forms disulfide-bonded homodimers that crosslink ZP2/ZP3 filaments; loss of ZP1 results in a loosely organized zona, defective cumulus-oocyte complex formation, and empty follicle syndrome in both rodent and primate models (PMID:10433913, PMID:40923306). ZP1 is synthesized exclusively by oocytes and traffics through the Golgi apparatus and vesicular intermediates before secretion, a process that depends on co-expression with ZP2 and ZP3, since mutant ZP1 proteins sequester ZP3 (and ZP4 in non-murine species) intracellularly and block zona assembly (PMID:11906903, PMID:24670168, PMID:33624742). Homozygous or compound heterozygous loss-of-function mutations in human ZP1 cause zona pellucida deficiency and female infertility presenting as empty follicle syndrome (PMID:24670168, PMID:31734689).

1. 1996 Medium

   Before ZP1's structural role was established, recombinant porcine ZP1 was shown to function as a secondary sperm receptor that binds acrosome-reacted spermatozoa and proacrosin, indicating ZP1 participates directly in gamete recognition beyond matrix formation.

   Evidence Immunofluorescence binding assay and immunoblotting with recombinant pZP1 and boar sperm extracts

   PMID:8984189

   Open questions at the time

   • Binding was demonstrated only in pig; relevance to human or mouse ZP1 not tested
   • Identity of the 40 kDa sperm binding partner unresolved
   • No in vivo validation of secondary receptor function
2. 1999 High

   Mouse Zp1 knockout established that ZP1 is required for structural integrity of the zona pellucida — without it, a zona still forms from ZP2/ZP3 but is loosely organized — resolving the question of whether ZP1 is a structural crosslinker versus an essential assembly factor.

   Evidence Targeted Zp1 gene knockout in mice with histological, hormonal, and mating analyses

   PMID:10433913 PMID:10526650

   Open questions at the time

   • Molecular mechanism of crosslinking (disulfide topology) not resolved at atomic level
   • Whether ZP1 loss affects sperm binding independently of zona loosening was uncertain
3. 2002 High

   Immunoelectron microscopy resolved that ZP1 is synthesized exclusively by oocytes and traffics through the Golgi and vesicular aggregates before secretion, establishing the biosynthetic pathway and ruling out granulosa cell contribution.

   Evidence Protein A-gold immunoelectron microscopy with double/triple immunolocalization in mouse ovarian follicles

   PMID:11906903

   Open questions at the time

   • Signals controlling ZP1 sorting from Golgi to secretory vesicles not identified
   • Asymmetric distribution of ZP proteins in the matrix mechanistically unexplained
4. 2004 Medium

   Co-expression studies demonstrated that ZP1 secretion requires co-expression with ZP2 and ZP3, establishing that ZP protein hetero-interactions are prerequisite for secretion rather than just extracellular assembly.

   Evidence Co-expression of recombinant human ZP proteins in HEK 293T cells with Western blotting of medium and lysate

   PMID:15064827

   Open questions at the time

   • Which domain of ZP1 mediates the co-secretion interaction was not mapped
   • Whether ZP1 secretion also requires ZP4 in human oocytes was not tested
5. 2013 Medium

   Biophysical characterization of ZP1-N domain peptides revealed amyloid-like fibril self-assembly, suggesting a polymerization mechanism for zona matrix formation beyond simple disulfide crosslinking.

   Evidence TEM, X-ray diffraction, Congo red staining, and ATR FT-IR spectroscopy of synthetic ZP1-N peptides

   PMID:24069181

   Open questions at the time

   • Whether amyloid-like assembly occurs in vivo within the zona is unresolved
   • Contribution of amyloid-like polymerization relative to disulfide crosslinking not quantified
   • Only two short peptides tested — full ZP-N domain behavior unknown
6. 2014 High

   A human homozygous frameshift ZP1 mutation was shown to cause intracellular sequestration of ZP3 by defective ZP1, directly linking ZP1 loss-of-function to human infertility through a dominant-negative intracellular trapping mechanism.

   Evidence Whole-exome sequencing of infertile pedigree combined with co-localization studies in transfected cells

   PMID:24670168

   Open questions at the time

   • Whether heterozygous carriers have subclinical zona thinning was not assessed
   • Rescue experiment restoring ZP1 was not performed
7. 2018 Medium

   ZP1 ubiquitination by the proteasome pathway was linked to sperm-binding competence, revealing a post-translational regulatory layer on zona function beyond assembly.

   Evidence PSMD4 antibody-mediated inhibition in porcine oocytes with ubiquitination Western blotting and sperm binding assay

   PMID:29575084

   Open questions at the time

   • Direct E3 ligase responsible for ZP1 ubiquitination not identified
   • Whether ubiquitination modifies ZP1 surface exposure versus degradation unclear
   • Only shown in porcine system
8. 2019 Medium

   Multiple human ZP1 mutation studies converged to show that pathogenic variants disrupt ZP1–ZP2 and ZP1–ZP3 interactions as assessed by co-immunoprecipitation, establishing interaction loss as the common molecular defect underlying zona absence and empty follicle syndrome.

   Evidence Co-immunoprecipitation, Western blotting, and homology modeling of wild-type and mutant ZP proteins in CHO/CHO-K1 cells across multiple patient cohorts

   PMID:30810869 PMID:31292994 PMID:31734689

   Open questions at the time

   • Binding interfaces between ZP1 and ZP2/ZP3 not structurally resolved
   • Genotype-phenotype correlation across different mutation types not systematically established
9. 2021 High

   A rat knock-in model demonstrated that a truncated ZP1 acts as a dominant-negative by binding and sequestering ZP3 and ZP4 intracellularly, extending the intracellular trapping mechanism from in vitro systems to an in vivo mammalian model.

   Evidence Rat Zp1 knock-in mutant with co-IP, immunofluorescence, and superovulation/fertilization assays

   PMID:33624742

   Open questions at the time

   • Whether ZP4 sequestration contributes to human pathology (humans express ZP4) not confirmed
   • Threshold level of ZP1 needed for functional zona not determined
10. 2025 High

    CRISPR knockout of ZP1 in cynomolgus macaques confirmed that ZP1 is essential for zona pellucida assembly and normal folliculogenesis in primates, validating the translational relevance of rodent findings to the human four-ZP-protein system.

    Evidence CRISPR/Cas9 knockout in non-human primates with immunofluorescence, TEM, transcriptomics, and histopathology

    PMID:40923306

    Open questions at the time

    • Downstream transcriptomic changes not mechanistically dissected
    • Whether ZP1-null primate oocytes can be rescued by exogenous ZP1 is untested

• The atomic-resolution structure of ZP1 homodimer and its interfaces with ZP2/ZP3 filaments remain unresolved, leaving the precise mechanism of crosslink formation and the determinants of species-specific zona architecture unknown.
• No crystal or cryo-EM structure of ZP1 homodimer or ZP1-ZP2/ZP3 complex
• Disulfide bond topology of the crosslink not mapped
• Molecular basis of species differences in ZP composition (3 vs 4 ZP proteins) not mechanistically explained